MUSE Microscopy, Inc. Launches Veterinary Digital Pathology with the First-of-Its-Kind Tissue-to-Direct Digital Imaging for the Veterinary MarketIRVINE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a pioneer in digital pathology innovation, today announced the formation of MUSE Veterinary Digital Pathology, LLC, a wholly-owned subsidiary focused on transforming pathology through point-of-care service. This initiative aims to provide same-day results for tissue biopsies. This new service will provide the gold standard of patient care allowing veterinarians to deliver pet parents with diagnosis, prognosis, and treatment plans efficiently using the SmartPath MUSE Technology™ (SmartPath)* Platform.
MUSE Microscopy, Inc. Welcomes Dr. Derek C. Welch to Board of Directors, Appoints Him Chair of Science & Technology CommitteeIRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a pioneer in digital pathology innovation, proudly announces the appointment of Dr. Derek C. Welch, MD, FCAP, to its Board of Directors. Dr. Welch, the President and Chief Medical Officer of PathGroup, brings over two decades of leadership in pathology and laboratory medicine. He will also serve as Chair of the Science & Technology Committee, collaborating closely with CEO Matthew Nuñez to advance SmartPath MUSE Technology™ (SmartPath)* platform.
Leading with Light: MUSE Microscopy Illuminates the Next Era of Oncology at ASCOIRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, (the “Company”, “we”, “our”) a leader in slide-free, tissue-to-digital™ pathology solutions, is excited to announce its participation in the upcoming American Society of Clinical Oncology (ASCO) 2025, taking place from May 30 – June 03 in Chicago, IL. Following our successful introduction of SmartPath MUSE Technology™ (SmartPath), the first tissue-to-digital imager utilizing Microscopy with Ultraviolet Surface Excitation (MUSE) at the recent USCAP25 in Boston, we are eager to demonstrate our innovative technology at ASCO.
Take the Lead: Forward a New Evolution in Slide-Free Pathology with MUSE Microscopy’s Groundbreaking SmartPath TechnologyIRVINE, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a pioneer in digital pathology innovation, is proud to announce the development of its revolutionary slide-free, digital tissue imaging platform. This cutting-edge technology is set to redefine traditional histology workflows by enabling the generation of high-quality digital tissue images in minutes—at a fraction of the time required for conventional FFPE slide processing. With this advancement, pathologists have the potential to rapidly access images to reduce the total turnaround time.
MUSE Microscopy Showcasing SmartPath MUSE Technology and Appointment of Yanbin (Eric) Qiang as President of Asia MarketsIRVINE, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc. (the “Company”, “we”, “our”) is thrilled to announce the introduction of SmartPath MUSE Technology™ (SmartPath), the pioneering tissue-to-digital Imager utilizing MUSE (Microscopy with Ultraviolet Surface Excitation) technology, specifically designed for pathology applications. This innovative solution aims to revolutionize the histology process, which has remained largely unchanged for over a century, by eliminating the need for traditional slide-based methods.
MUSE Microscopy, Inc. is Entering a New Era of Digital Pathology with the Development of the SmartPath MUSE Technology (SmartPath) ImagerIRVINE, Calif., Nov. 26, 2024 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a innovator in digital pathology announced it’s in their final phase. After a strategic acquisition by the current leadership team in 2021, MUSE has steadfastly pursued a visionary roadmap that has the potential to reshape the future of digital pathology. Today, that journey reaches an exciting moment with SmartPath MUSE Technology™ (SmartPath)—the industry’s first tissue-to-digital™ imager using MUSE (Microscopy with Ultraviolet Surface Excitation) technology, intended to create a solution that eliminates the need for traditional slide-based histology, a fundamental process that has remained unchanged for over a century.
Pivotal Developmental Milestone Unveiled by MUSE Microscopy, Inc. at CAP24 Pathology ConferenceIRVINE, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., has reached a pivotal developmental milestone, unveiling a preliminary version of its innovative SmartPath Imager at the recent CAP24 Pathology Conference in Las Vegas, NV. We introduced SmartPath as the first tissue-to-digital™ imager utilizing MUSE (Microscopy with Ultraviolet Surface Excitation) which we intend to create a solution that eliminates the need for traditional slide-based histology, a fundamental process that has remained unchanged for over a century.
